In this Issue:

  • Events
     
    - AFAR Annual Awards Dinner
      - Biomarkers of Aging Scientific Conference
  • Our Grantees
     
    - In the Lab With... Lee Goldstein, MD, PhD
      - AFAR Grantees in the News
  • Grants Update
  • Spotlight on: The Fannie E. Rippel Foundation
  • People News

____________________________________________________________________

Events

Save the Dates - October 1 and 2, 2007

Sustaining the Momentum - AFAR's Annual Awards Dinner

Please join AFAR on October 1, 2007 as we celebrate the remarkable advances occurring in the field of aging research and recognize those individuals, corporations and foundations that have made significant contributions.

Honorees include: Richard A. Miller MD, PhD, Professor of Pathology and Associate Director of the Geriatrics Center at the University of Michigan; long-time AFAR Board member Diane A. Nixon; Allen D. Roses, MD, Senior Vice President, Pharmacogenetics, GlaxoSmithKline; Launny Steffens, former Vice Chair at Merrill Lynch; and T. Franklin Williams, MD, former head of the National Institute on Aging.

For more information, contact Nancy O'Leary at nancy@afar.org or 212-703-9977.


Seeking Biomarkers of Aging and Diseases of Aging

On October 2, 2007, AFAR will host a premier scientific conference, Seeking Biomarkers of Aging and Diseases of Aging that will assess the existing biomarkers available and explore the kinds of biomarkers needed to provide improvements to the human condition by alleviating disease and extending healthy lifespan. The conference will also provide a forum for industry and basic scientists to explore opportunities for collaboration to develop more useful biomarkers and effective interventions that could ultimately identify in the pre-symptomatic stage, treat and track age-related diseases and disorders.

Richard Hodes, MD, Director of the National Institute on Aging (NIA) will be the keynote speaker. Other participants include: Luigi Ferrucci, MD, PhD, NIA/Baltimore Longitudinal Study on Aging; Stephen Helfand, MD, Brown University; Donald Ingram, PhD, NIA; George M. Martin, MD, University of Washington; Gerald McClearn, PhD, Penn State University; Richard Miller, MD, PhD, University of Michigan; Richard Sprott, PhD, Ellison Medical Foundation; Richard Weindruch, PhD, University of Wisconsin; and Terrie Fox Wetle, PhD, Brown University.

Sponsors to date include: anonymous, 2007 Dorothy Dillon Eweson Lecture Series, The Ellison Medical Foundation, GE Healthcare, GlaxoSmithKline, The Glenn Foundation for Medical Research, Ortho-McNeil Neurologics, Inc., and sanofi-aventis. For more information and to register, please visit http://www.afar.org/biomarkersconference.html or contact Stacey Harris at Stacey@afar.org or 212-703-9977.

Both events will be held at the University Club located at 1 West 54th Street in New York City.


Our Grantees

In the Lab With... Lee Goldstein, MD, PhD, 2004 Beeson Scholar
To learn more about the Paul B. Beeson Career Development Awards in Aging Research Program, please go to our website.

"No way! No one else has found this. What makes you think you could?" That, according to Lee Goldstein, MD, PhD, was the general reaction to his discovery of unusual amyloid cataracts that may herald the onset of Alzheimer's disease (AD).

It happened quite by accident early in the research career of Goldstein, who is now Director of the Molecular Aging & Development Laboratory and Associate Director of the Center for Ophthalmic Research, both at the Brigham & Women's Hospital in Boston, MA, and Assistant Professor of Psychiatry at the Harvard Medical School. "I was measuring hydrogen peroxide in the brains of Alzheimer's mice," he says, "when some previous research experience in ophthalmology came in very handy. I noticed that my mice were developing dense bilateral cataracts in their eyes- at an age when mice simply don't get cataracts. This is very unusual. So I took a look at a few more of the Alzheimer's mice, and they all had the same cataract."

Healthy, wild-type control mice, on the other hand, showed no signs of similar cataracts. Goldstein then looked at eyes from people with Alzheimer's disease, and to his astonishment, found the same unusual cataracts. He determined that the cataracts were composed of the same protein, b-amyloid, that forms sticky, tangled plaques in the brains of Alzheimer's patients. He and his team reported their discoveries in the medical journal, The Lancet. Read more.


Grantees in the News

Many AFAR grantees are gaining attention for their research in high-profile media, helping AFAR better communicate to the public the importance of supporting such research. Here are some highlights. You may read the full listing on our website.

A March 26, 2007 Newsweek cover story about exercise and the brain featured two AFAR-supported scientists: Scott Small, MD, of Columbia University and Kristine Yaffe, MD, of the University of California, San Francisco, both recipients of the Paul Beeson Career Development Award in Aging Research, a partnership program supported by AFAR. Dr. Small discussed the results of his research showing that humans who exercised regularly during a three-month period grew new brain cells in the areas of the brain that controlled learning and memory. Dr. Yaffe commented about the additional cognitive benefits of exercise.

Anne Cappola, MD, of the University of Pennsylvania School of Medicine and Mark Lachs, MD, of The New York Presbyterian Health System/Weill Cornell appeared on the WABC-TV program Viewpoints on March 18, 2007 to discuss how men and women age. Dr. Cappola's research focuses on hormonal alterations that occur with aging and the clinical impact these changes have in older women, particularly with regard to rates of aging and frailty. Her innovative research may lead to a design of a new form of hormone replacement therapy that will help slow the development of sarcopenia, a condition that develops with age. Dr. Cappola is a 2001 recipient of the AFAR/Pfizer Research Grant in Hormones and Aging. Dr. Lachs, Director of Geriatrics at The New York Presbyterian Health System and Irene F. and I. Roy Psaty Distinguished Professor of Medicine and Co-chief of the division of Geriatric Medicine and Gerontology at the Weill Medical College of Cornell University, is a preeminent geriatrician and authority on the issue of elder abuse. He is a recipient of the Beeson award and a current AFAR board member.

Research conducted by Scott Pletcher, PhD, at Baylor College of Medicine and the first recipient of the Glenn/AFAR Breakthroughs in Gerontology (BIG) Award showed that the life-lengthening effects of caloric restriction were negated by the odor of yeast paste in fruit flies. The study, reported in the journal Science in February 2007, found that the flies that could smell rich food in the environment lived shorter lives than flies that ate the same amount of food but were not exposed to the odorant. Dr. Pletcher's research was featured in The Scientist, Scientific American, Nature and Slate .

NOVA scienceNOW, the acclaimed science series on PBS, featured a 13-minute broadcast segment on aging and longevity genes. The segment, which aired January 9, 2007, included interviews with Nir Barzilai, MD, of the Albert Einstein College of Medicine (1994 AFAR Research Grant recipient and 1997 Beeson Scholar) and David Sinclair, PhD, of Harvard University (2000 AFAR Research Grant recipient). To watch the segment or view additional materials, visit the NOVA scienceNOW web site.


Grants Update

Beeson Program Expands

The renowned Paul Beeson Career Development Awards in Aging Research Program has launched two additional spin-off projects:

With support from The Atlantic Philanthropies, the Beeson program went international with one award of up to approximately $450,000 to be awarded each year for five years to an outstanding junior physician faculty member on the Island of Ireland. With this expansion, the program continues to build a cadre of leading physician-scientists who are committed to academic careers in aging-related research, teaching, and practice.

The John A. Hartford Foundation also awarded AFAR a grant to fund interdisciplinary teams of alumni from the Beeson program to spur new directions in the understanding and treatment of diseases associated with aging. Known as the Hartford Collaborative Research Awards: Paul B. Beeson Career Development Scholars Program, this grant will allow Beeson Scholars, already identified as top investigators in aging research, to collaborate on research that spans traditional disciplinary boundaries and prepare for larger federal grants.


Centers of Excellence Network Resource Center

Since 2005, with support from the John A. Hartford Foundation, AFAR has served as the Network Resource Center for the Foundation's 24 Centers of Excellence (CoEs), recognized for their considerable capacity to recruit and develop physician leaders in geriatrics. The role of the Network Resource Center is to facilitate communications among the CoEs and to identify and disseminate tested approaches in geriatrics recruitment and career development. Three major products on these topics are planned between now and 2008.


GE Healthcare to Sponsor Prize for Junior Investigators

For the second straight year, GE Healthcare will underwrite a junior investigator award in conjunction with AFAR's scientific conference, Seeking Biomarkers of Aging and Diseases of Aging. The AFAR-GE Healthcare Junior Investigator Award for Excellence in Biomarker Research will recognize the most innovative biomarker research related to aging and age-related diseases. To apply, please visit: http://www.afar.org/GEaward.html. For additional questions, please contact Veronica Smith at geaward@afar.org or call 212-703-9977.


Meeting Dates

Beeson Annual Meeting - June 21-24, 2007, Tarrytown, NY
This meeting is held for Scholars, mentors and other leaders in academic medicine and aging research to review research progress of Scholars, encourage dissemination of their findings, and enhance development of scholarship and leadership.

AFAR Grantee Conference - October 1-2, 2007, New York City (to be held in conjunction with AFAR's scientific conference, Seeking Biomarkers of Aging and Diseases of Aging).
The purpose of this annual conference is to promote scientific and personal exchanges among recent AFAR grantees and experts in the fields of geriatrics and gerontology.


SPOTLIGHT ON: The Fannie E. Rippel Foundation

To address the need for more study about the effects of aging on men and women, AFAR partnered with the Fannie E. Rippel Foundation to create one of our newest grant programs: The Fannie E. Rippel Foundation/AFAR New Investigator Awards on Gender Differences in Aging. The program supports early-career scientists using a gender-based approach to aging research.

"We were very interested in supporting research that could yield critical information specific to older men and women's health," said Laura Landy, President of the Fannie E. Rippel Foundation. "Men's and women's biology and physiology are different and many of the diseases of aging affect them differently in terms of occurrence and progression. We are pleased to collaborate with AFAR to support this relatively new and much-needed area of medical research."

The Fannie E. Rippel/AFAR awards will provide grants of up to $60,000 each to two junior investigators in 2007 covering such areas as the role of sex hormones, immune function, neurobiology, cardiovascular aging and the biology of menopause.

"This research will have an enormous impact on the health of older men and women, said Stephanie Lederman, Executive Director of AFAR. "We thank the Fannie E. Rippel Foundation for their forward-thinking support of this innovative grant program."

The Fannie E. Rippel Foundation, located in Basking Ridge, New Jersey, was established in 1953 with an endowment from Julius S. Rippel, who named the healthcare philanthropy for his wife. The foundation awards $4 to $5 million in grants annually.


People

AFAR Leadership to Speak at the Aspen Health Forum

AFAR President Terrie Fox Wetle, PhD, and Executive Director Stephanie Lederman will be among the premier speakers at the Aspen Health Forum, on October 3-6, 2007. Organized by the Aspen Institute and The Atlantic magazine, the program will bring together the world's most foremost scientists, clinicians, policymakers and health leaders to discuss challenging issues and exciting developments in medical science. For more information and to reserve a space at the conference, please visit www.aspeninstitute.org/healthforum.


AFAR Mourns the Passing of Hinda Rosenthal

AFAR celebrates the life and mourns the death of long-time supporter, Hinda Rosenthal, who we recently honored at our 25th anniversary awards dinner.

As President of the Richard and Hinda Rosenthal Foundation, Hinda Rosenthal was committed to the ideal that those who secure unusual benefits from society have the obligation to give a significant portion back. The Foundation's Awards in Medicine have made notable contributions to improved clinical treatment in cancer, cardiovascular disease, internal medicine, and in the delivery of patient treatment. The Foundation's uninterrupted support of AFAR began in 1995.

We extend our deepest gratitude to Mrs. Rosenthal for her contributions and work on behalf of AFAR. Her life and actions contributed greatly to advancing the field of aging research.


Georgetown University Names AFAR Board Member Howard Federoff, to Lead Post

Howard Federoff, MD, PhD, was named Executive Vice President for Health Sciences and Executive Dean of Georgetown University's School of Medicine, effective April 1, 2007. In this position, Dr. Howard Federoff will oversee the medical school's research enterprises. An AFAR board member since 2002, Dr. Federoff directed AFAR's upstate New York affiliate. He was formerly Senior Associate Dean for Basic Research and Professor of Oncology and Genetics at the University of Rochester School of Medicine and founding director of the Center for Aging and Development Biology at the Aab Institute for Biomedical Sciences. Dr. Federoff's research interests include gene therapy and neurodegenerative diseases.


Other People News

  • Stephanie Lederman was elected a Fellow of the New York Academy of Medicine.
  • AFAR welcomes new board members: Steven Austad, PhD, of the University of Texas; Jay Edelberg, MD of GlaxoSmithKline, William Lipton, of Ernst & Young LLP (retired); and Alastair J.J. Wood of Symphony Capital.


For more information about the work of AFAR, please visit our organizational web site www.afar.org and our web site for the general public, Infoaging (www.infoaging.org).